IL-17C and Its Receptor IL-17RA/IL-17RE Identify Human Oral Epithelial Cell As an Inflammatory Cell in Recurrent Aphthous Ulcer
Overview
Authors
Affiliations
Background: Recurrent aphthous ulcer (RAU) is an ulcerative disease of non-keratinized oral mucosa. Colon and bronchial epithelial cells produce interleukin-17C (IL-17C) upon stimulation of Toll-like receptor 2 (TLR2), TLR3 and TLR5, which are highly expressed in epithelial cells in RAU lesions. We therefore investigated the eventual presence and function of IL-17C in cultured human oral keratinocytes (HOK) and control biopsies compared to RAU lesions.
Methods: Expression of IL-17A, IL-17C, IL-17RA and IL-17RE was analysed in cultured HOK cells using quantitative real-time polymerase chain reaction (qRT-PCR). HOK cells were stimulated with IL-17C and analysed for IL-8 and tumour necrosis factor-α (TNF-α) using qRT-PCR. Control mucosa (n = 5) was immunostained for IL-17A, IL-17C, IL-8, TNF-α and mast cell tryptase and compared with RAU lesions (n = 5) using the mean grey scale value.
Results: IL-17C, but no IL-17A, mRNA was found in cultured HOK cells. Components of the heterodimeric IL-17RA/IL-17RE receptor for IL-17C were also highly expressed. Stimulation of HOK with IL-17C increased TNF-α mRNA (P = 0.03; IL-8 increase was not statistically significant). HOK in RAU lesions stained intensively for IL-17C compared to controls (P = 0.006). This was associated with increased epithelial immunostaining of TNF-α (P = 0.04) and IL-8 (P = 0.02). Most of the inflammatory cells which stained for IL-17A in control mucosa and RAU lesions were also mast cell tryptase positive.
Conclusion: IL-17C is highly expressed in epithelial cells in RAU lesions, where it seems to stimulate oral keratinocytes via IL-17RA/IL-17RE to produce pro-inflammatory cytokines. Human oral epithelial cells are probably important inflammatory cells in RAU.
Zhang X, Fan H, Zhang X, Wang Y, Chen G Health Sci Rep. 2025; 8(2):e70405.
PMID: 39980825 PMC: 11839742. DOI: 10.1002/hsr2.70405.
Role and functional mechanisms of IL‑17/IL‑17R signaling in pancreatic cancer (Review).
Liu W, Wang X, Wu W Oncol Rep. 2024; 52(5).
PMID: 39219271 PMC: 11378154. DOI: 10.3892/or.2024.8803.
Aji N, Yucel-Lindberg T, Raisanen I, Kuula H, Nieminen M, Mc Crudden M Diagnostics (Basel). 2024; 14(10).
PMID: 38786309 PMC: 11119995. DOI: 10.3390/diagnostics14101011.
Zhong W, Tao S, Guo X, Cheng X, Yuan Q, Li C Medicine (Baltimore). 2023; 102(34):e34744.
PMID: 37653793 PMC: 10470703. DOI: 10.1097/MD.0000000000034744.
Targeting Th17 cells: a promising strategy to treat oral mucosal inflammatory diseases.
Wang Y, Xue N, Wang Z, Zeng X, Ji N, Chen Q Front Immunol. 2023; 14:1236856.
PMID: 37564654 PMC: 10410157. DOI: 10.3389/fimmu.2023.1236856.